Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Critical Care Medicine

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00003246-199902000-00038PMID 10075056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward a new reference method for the leukocyte five-part differential.

  1997cited by this paper
• Tumor necrosis factor: function, release and clearance.

  1996cited by this paper
• Tumor necrosis factor and the systemic inflammatory response syndrome.

  1996cited by this paper
• High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients.

  1996cited by this paper
• IMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSIS: MEDIATORS, MACROPHAGES, LYMPHOCYTES AND APOPTOSIS

  1996cited by this paper
• Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis.

  1996cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Lymphocyte-derived cytokines augment macrophage tumor necrosis factor-alpha and interleukin-6 secretion during experimental gram-negative bacterial sepsis.

  1995cited by this paper
• Regulation of NK cells through the 80‐kDa TNFR (CD120b)

  1995cited by this paper
• Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans.

  1995cited by this paper
• Two tumour necrosis factor receptors: structure and function.

  1995cited by this paper
• Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils.

  1994cited by this paper
• Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia

  1994cited by this paper
• Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.

  1994cited by this paper
• Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis.

  1994cited by this paper
• Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.

  1994cited by this paper
• Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

  1994cited by this paper
• TNF induces internalization of the p60 receptor and shedding of the p80 receptor.

  1994cited by this paper
• Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections.

  1994cited by this paper
• Tumor necrosis factor: An updated review of its biology

  1993cited by this paper
• Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

  1993cited by this paper
• Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

  1993cited by this paper
• Human sepsis increases lymphocyte intracellular calcium

  1993cited by this paper
• Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.

  1993cited by this paper
• Tumor necrosis factor in the pathogenesis of infectious diseases

  1993cited by this paper
• Influence of an anti‐tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

  1993cited by this paper
• Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

  1993cited by this paper
• Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

  1993cited by this paper
• Expression of membrane receptor for tumour necrosis factor on human blood lymphocytes

  1993cited by this paper
• A novel domain within the 55 kd TNF receptor signals cell death.

  1993cited by this paper
• Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.

  1992cited by this paper
• Plasma tumor necrosis factor soluble receptors in chronic renal failure.

  1992cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper
• The febrile response in critical care: state of the science.

  1992cited by this paper
• The two different receptors for tumor necrosis factor mediate distinct cellular responses.

  1991cited by this paper
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level

  1991cited by this paper
• Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.

  1991cited by this paper
• Regulation of lymphocyte tumor necrosis factor receptors by IL-2.

  1989cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• Comparison of Several Regression Procedures for Method Comparison Studies and Determination of Sample Sizes Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II

  1984cited by this paper
• A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I

  1983cited by this paper
• Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis.

  1978cited by this paper

• Current problems in burn immunology.

  2020cites this paper
• Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

  2019cites this paper
• The systemic inflammatory response syndrome

  2018cites this paper
• Zytokine als Marker bei Polytrauma

  2014cites this paper
• Zytokine als Marker bei Polytrauma

  2014cites this paper
• SÍNDROME DE DISFUNÇÃO DE MÚLTIPLOS ÓRGÃOS INDUZIDA POR SEPSE: ESTUDO EXPERIMENTAL EM RATOS Sepsis inducing syndrome of multiple organ dysfunction: an experimental study in rats

  2011cites this paper
• SEPSIS MODEL TO INDUCE SYNDROME OF MULTIPLE ORGAN DYSFUNCTION : AN EXPERIMENTAL STUDY IN RATS

  2011cites this paper
• Pathogenetic Changes: Isolated Extremity Trauma and Polytrauma

  2010cites this paper
• Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis

  2008cites this paper
• Reprogramming of circulatory cells in sepsis and SIRS

  2005cites this paper
• Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.

  2004cites this paper
• Immune Reactions after Trauma

  2003influential citation
• Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator.

  2002cites this paper
• Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome

  2002cites this paper
• The Clinical Usefulness of the Measurement of Cytokines

  2000cites this paper
• A debate on the subject "Are SIRS and MODS important entities in the clinical evaluation of patients?" The con position.

  2000cites this paper
• Multiple organ failure – the discrepancy between our scientific knowledge and understanding and the management of our patients

  2000cites this paper
• Tumor necrosis factor receptor expression on inflammatory cells in sepsis.

  1999cites this paper